Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 21, 2017; 23(27): 4897-4909
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4897
Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4897
Table 1 Study samples
Sample | n | Sex, n | Race, n | Age at diagnosis |
IBD | 159 | Male, 85; female, 74 | White, 153; black, 6 | 13.1 |
CD | 136 | Male, 77; female, 59 | White, 130; black, 6 | 13.1 |
CCFA | 118 | Male, 65; female, 53 | White, 112; black, 6 | 13.0 |
Hershey | 18 | Male, 12; female, 6 | White, 18 | 13.4 |
UC | 23 | Male, 9; female, 14 | White, 23 | 13.3 |
CCFA | 10 | Male, 5; female, 5 | White, 10 | 12.9 |
Hershey | 13 | Male, 4; female, 9 | White, 13 | 13.6 |
Control | 129 | Male, 65; female, 64 | White, 121; black, 7; unknown, 1 | 17.5 |
Table 2 Study single nucleotide polymorphisms for IL-10, IL10RA, IL10RB, STAT3 and HO1 genes
Gene | SNP ID | Chromosomal position | Variation | Gene location | Disease implication | Ref. |
IL-10 | rs1800872 | 206946407 | C-592>A | 5'-upstream | associated with IBD | [37] |
rs3024498 | 206941529 | c.T>C | 3'-untralated region | associated with colorectal cancer | [41] | |
rs3024496 | 206941864 | A>G | 3'-untralated region | associated with IBD and colorectal cancer, with decreased IL-10, with increased IgE levels | [37-39,41] | |
IL10RA | rs3135932 | 117864063 | c.A247>G, p.Ser159Gly | coding region | mutations (other than the studied SNP) associated with pediatric IBD | [7,10,12] |
IL10RB | rs2834167 | 34640788 | c.A>G, p.Lys(A)47Glu(G) | coding region | mutations (other than the studied SNP) associated with pediatric IBD | [7-11] |
STAT3 | rs744166 | 404514201 | A>G | Intron 1 (closer to exon2) | associated with IBD | [20] |
HO1 | rs2071746 | 3577672 | A413>T | 5'-upstream | no association with IBD, associated with asthma and allergy, anti-inflammation, anti-oxidant | [30,31] |
Table 3 PCR-RFLP method for genotyping IL-10, IL10RA, IL10RB, STAT3 and HO1 genes
Gene | SNP ID | Variant | PCR amplification | RFLP | ||
Primers1 | Product, bp | Restriction enzyme | Recognition site | |||
IL-10 | rs1800872 | G>T | IL-2f: 5'-AACTTAGGCAGTCACCTTAGG-3' | 149 | ScaI | T yes; G No |
IL-2r: 5'-CATCCTGTGACCCCTCCAGT-3' | ||||||
rs3024498 | T>C | IL-5f: 5'-GCTCCtTGGTTTCTCTTCCTA AG-3' | 137 | HpyCH4V | C yes; T No | |
IL-5r: 5'-AGAAGCTTCCATTCCAAGCC TGA-3' | ||||||
rs3024496 | A>G | IL-4f: 5'-GTATCAGAGGTAATAAATATTCcAT-3' | 178 | NlaIII | G yes; A No | |
IL-4r: 5'-TAGAAGCATACATGACAATGAAG-3' | ||||||
IL10RA | rs3135932 | A>G | RA3f: 5'-CCCGCAAATGACACATATGgA-3' | 172 | MnI | G yes; A No |
RA3r: 5'-AGTTCCCAATGGCACACAAGG-3' | ||||||
IL10RB | rs2834167 | A>G | RB3f: 5'-GCCATAGAGGAGAACCAAGTG-3' | 206 | CarI | G yes; A No |
RB3r: 5'-GCTGTGAAAGTCAGGTTCTCTT-3' | ||||||
STAT3 | rs744166 | A>G | ST2f: 5'-CAGGAGTGCCAACATTGAGAG-3' | 106 | AluI | A yes; G No |
ST2r: 5'-G TAATGTCTTGAGGGAATCGAG-3' | ||||||
HO1 | rs2071746 | A>T | HO4f: 5'-TCAGCAGAGGATTCCAGCAGG-3' | 110 | BfaI | A yes; T No |
TG-3' HO4r: 5'-AGGCAGCGCTGCTCAGAGCAC-3' |
Table 4 Genetic association of IL-10, IL10RA, IL10RB, STAT3 and HO1 genes with pediatric inflammatory bowel disease
Gene | SNP ID | Genotype | Disease, n | Control, n | OR | 95%CI | P value |
IL-10 | rs1800872 | CC | 89 | 78 | 0.863 | 0.564-1.313 | 0.71 |
CA | 68 | 50 | |||||
AA | 2 | 1 | |||||
C allele | 246 | 206 | |||||
A allele | 72 | 52 | |||||
rs3024498 | CC | 86 | 77 | 0.830 | 0.552-1.244 | 0.616 | |
CT | 65 | 47 | |||||
TT | 8 | 5 | |||||
C allele | 237 | 201 | |||||
T allele | 81 | 57 | |||||
rs3024496 | AA | 57 | 27 | 1.487 | 1.055-2.099 | 0.022 | |
AG | 69 | 69 | |||||
GG | 33 | 33 | |||||
A allele | 183 | 123 | |||||
G allele | 185 | 135 | |||||
IL10RA | rs3135932 | AA | 108 | 85 | 0.925 | 0.595-1.433 | 0.160 |
AG | 39 | 40 | |||||
GG | 12 | 4 | |||||
A allele | 255 | 210 | |||||
G allele | 63 | 48 | |||||
IL10RB | rs2834167 | AA | 91 | 64 | 1.318 | 0.884-1.968 | 0.203 |
AG | 66 | 60 | |||||
GG | 2 | 5 | |||||
A allele | 248 | 188 | |||||
G allele | 70 | 70 | |||||
STAT3 | rs744166 | GG | 64 | 49 | 0.943 | 0.662-1.340 | 0.352 |
AG | 66 | 63 | |||||
AA | 29 | 17 | |||||
A allele | 194 | 161 | |||||
G allele | 124 | 97 | |||||
HO1 | rs2071746 | AA | 32 | 30 | 0.957 | 0.680-1.348 | 0.634 |
AT | 96 | 71 | |||||
TT | 31 | 28 | |||||
A allele | 158 | 131 | |||||
T allele | 160 | 127 |
Table 5 Epistatic interaction between two single nucleotide polymorphisms in three IL-10 single nucleotide polymorphisms studied
Epistatic model | rs3024496, P = 0.022, Bp = 0.0226 | rs3024498, P = 0.616; Bp = 1 | |
rs1800872, P = 0.71; Bp = 1 | aa | P = 0.00015; Bp = 0.003 | P = 0.638; Bp = 1 |
ad | P = 0.057; Bp = 1 | P = 0.605; Bp = 1 | |
da | P = 0.010; Bp = 0.216 | P = 0.977; Bp = 1 | |
dd | P = 0.239; Bp = 1 | P = 0.049; Bp = 1 | |
rs3024496, P = 0.022, Bp = 0.0226 | aa | P = 0.371; Bp = 1 | |
ad | P = 0.222; Bp = 1 | ||
da | P = 0.167; Bp = 1 | ||
dd | P = 0.584; Bp = 1 |
Table 6 Gene-gene interaction between IL-10 with IL10RA, IL10RB, STAT3, or HO1 in pediatric inflammatory bowel disease
Gene | SNP | Epistatic model | IL10RA rs3135932, P = 0.160; Bp = 1 | IL10RB rs2834167, P = 0.203; Bp = 1 | STAT3 rs744166, P = 0.352; Bp = 1 | HO1 rs2071746, P = 0.634; Bp = 1 |
IL-10 | rs1800872 | aa | P = 0.046; Bp = 1 | P = 0.029; Bp = 1 | P = 0.248; Bp = 1 | P = 0.910; Bp = 1 |
ad | P = 0.739; Bp = 1 | P = 0.107; Bp = 1 | P = 0.954; Bp = 1 | P = 0.617; Bp = 1 | ||
da | P = 0.056; Bp = 1 | P = 0.376; Bp = 1 | P = 0.117; Bp = 1 | P = 0.569; Bp = 1 | ||
dd | P = 0.126; Bp = 1 | P = 0.168; Bp = 1 | P = 0.036; Bp = 1 | P = 0.671; Bp = 1 | ||
rs3024498 | aa | P = 0.330; Bp = 1 | P = 0.062; Bp = 1 | P = 0.143; Bp = 1 | P = 0.898; Bp = 1 | |
ad | P = 0.068; Bp = 1 | P = 0.629; Bp = 1 | P = 0.032; Bp = 1 | P = 0.840; Bp = 1 | ||
da | P = 0.884; Bp = 1 | P = 0.307; Bp = 1 | P = 0.316; Bp = 1 | P = 0.607; Bp = 1 | ||
dd | P = 0.265; Bp = 1 | P = 0.644; Bp = 1 | P = 0.029; Bp = 1 | P = 0.790; Bp = 1 | ||
rs3024496 | aa | P = 0.021; Bp = 0.433 | P = 0.425; Bp = 1 | P = 0.538; Bp = 1 | P = 0.346; Bp = 1 | |
ad | P = 0.020; Bp = 0.426 | P = 0.495; Bp = 1 | P = 0.306; Bp = 1 | P = 0.741; Bp = 1 | ||
da | P = 0.081; Bp = 1 | P = 0.189; Bp = 1 | P = 0.234; Bp = 1 | P = 0.297; Bp = 1 | ||
dd | P = 0.967; Bp = 1 | P = 0.570; Bp = 1 | P = 0.402; Bp = 1 | P = 0.457; Bp = 1 | ||
IL10RB | rs2834167 | aa | P = 0.403; Bp = 1 | P = 0.251; Bp = 1 | P = 0.128; Bp = 1 | |
ad | P = 0.384; Bp = 1 | P = 0.956; Bp = 1 | P = 0.369; Bp = 1 | |||
da | P = 0.518; Bp = 1 | P = 0.776; Bp = 1 | P = 0.0018; Bp = 0.039 | |||
dd | P = 0.176; Bp = 1 | P = 0.072; Bp = 1 | P = 0.289; Bp = 1 |
Table 7 Epistatic interaction among the two IL-10 single nucleotide polymorphisms, rs1800872 and rs3024496, and IL10RA, IL10RB, STAT3, or HO1
Epistatic model | IL10RA rs3135932, P = 0.16; Bp = 1 | IL10RB rs2834167, P = 0.203; Bp = 1 | STAT3 rs744166, P = 0.352; Bp = 1 | HO1 rs2071746, P = 0.634; Bp = 1 | |
Two IL-10 SNPs: rs1800872 and rs3024496 aa: P = 0.0002; Bp = 0.003 | aaa | P = 0.003; Bp = 0.099 | P = 0.080; Bp = 1 | P = 0.175; Bp = 1 | P = 0.216; Bp = 1 |
aad | P = 0.130; Bp = 1 | P = 0.340; Bp = 1 | P = 0.920; Bp = 1 | P = 0.140; Bp = 1 |
Table 8 Epistatic interaction of IL10RB and HO1 with IL-10 (three single nucleotide polymorphisms), IL10RA, or STAT3
Epistatic model | IL-10 rs1800872, P = 0.71; Bp = 1 | IL-10 rs3024498, P = 0.616; Bp = 21 | IL-10 rs3024496, P = 0.022; Bp = 0.0226 | IL10RA rs3135932, P = 0.16; Bp = 1 | STAT3 rs744166, P = 0.352; Bp = 1 | |
aa IL10RB rs2834167 and HO1 rs2071746 | aaa | P = 0.029; | P = 0.545; | P = 0.255; | P = 0.023; | P = 0.049; |
Bp = 1 | Bp = 1 | Bp = 1 | Bp = 0.820 | Bp = 1 | ||
aad | P = 0.127; | P = 0.240; | P = 0.928; | P = 0.193; | P = 0.554; | |
Bp = 1 | Bp = 1 | Bp = 1 | Bp = 1 | Bp = 1 | ||
ad IL10RB rs2834167 and HO1 rs2071746 | ada | P = 0.394; | P = 0.824; | P = 0.242; | P = 0.444; | P = 0.436; |
Bp = 1 | Bp = 1 | Bp = 1 | Bp = 1 | Bp = 1 | ||
add | P = 0.976; | P = 0.406; | P = 0.327; | P = 0.644; | P = 0.649; | |
Bp = 1 | Bp = 1 | Bp = 1 | Bp = 1 | Bp = 1 | ||
da IL10RB rs2834167 and HO1 rs2071746 | daa | P = 0.00015; | P = 0.489; | P = 0.047; | P = 0.008; | P = 0.014; |
Bp = 0.005 | Bp = 1 | Bp = 1 | Bp = 0.287 | Bp = 0.491 | ||
dad | P = 0.072; | P = 0.140; | P = 0.388; | P = 0.205; | P = 0.977; | |
Bp = 1 | Bp = 1 | Bp = 1 | Bp = 1 | Bp = 1 | ||
dd IL10RB rs2834167 and HO1 rs2071746 | dda | P = 0.199; | P = 0.808; | P = 0.568; | P = 0.766; | P = 0.4731; |
Bp = 1 | Bp = 1 | Bp = 1 | Bp = 1 | Bp = 1 | ||
ddd | P = 0.694; | P = 0.958; | P = 0.007; | P = 0.181; | P = 0.057; | |
Bp = 1 | Bp = 1 | Bp = 0.242 | Bp = 1 | Bp = 1 |
- Citation: Lin Z, Wang Z, Hegarty JP, Lin TR, Wang Y, Deiling S, Wu R, Thomas NJ, Floros J. Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease. World J Gastroenterol 2017; 23(27): 4897-4909
- URL: https://www.wjgnet.com/1007-9327/full/v23/i27/4897.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i27.4897